Stereotactic Hypofractionated Radiation Therapy as a Bridge to Transplantation for Hepatocellular Carcinoma: Clinical Outcome and Pathologic Correlation
- 1 July 2012
- journal article
- conference paper
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 83 (3), 895-900
- https://doi.org/10.1016/j.ijrobp.2011.08.032
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Radiotherapy as a bridge to liver transplantation for hepatocellular carcinomaTransplant International, 2010
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinomaLiver Transplantation, 2007
- Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantationJournal of Surgical Oncology, 2006
- Fractionated Stereotactic Radiotherapy in Patients with Primary Hepatocellular CarcinomaJapanese Journal of Clinical Oncology, 2006
- Management of hepatocellular carcinomaJournal of Hepatology, 2005
- Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantationJournal of Hepatology, 2005
- Non‐resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention‐to‐treat and dropout from liver transplant waiting listClinical Transplantation, 2004
- Liver transplantation in patients with hepatocellular carcinomaLiver Transplantation, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000